3SBio, (FRA:YFK) Price-to-Tangible-Book : 19.31 (As of Apr. 29, 2024)

View and export this data going back to . Start your Free Trial

What is 3SBio, Price-to-Tangible-Book?

As of today (2024-04-29), 3SBio,'s share price is €12.55. 3SBio,'s Tangible Book per Share of Dec. 2016 for the quarter that ended in Dec. 2016 was €0.65. Hence, 3SBio,'s Price to Tangible Book Ratio of today is 19.31.

The historical rank and industry rank for 3SBio,'s Price-to-Tangible-Book or its related term are showing as below:

FRA:YFK' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.99 Med: 81.14 Max: 251
Current: 251

During the past 13 years, 3SBio,'s highest Price to Tangible Book Ratio was 251.00. The lowest was 4.99. And the median was 81.14.

FRA:YFK's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.65 vs FRA:YFK: 251.00

A closely related ratio is called PB Ratio. As of today, 3SBio,'s share price is €12.55. 3SBio,'s Book Value per Sharefor the quarter that ended in Dec. 2016 was €39.30. Hence, 3SBio,'s P/B Ratio of today is 0.32.

3SBio, Price-to-Tangible-Book Historical Data

The historical data trend for 3SBio,'s Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Price-to-Tangible-Book Chart

3SBio, Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec14

Dec15

Dec16

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.24

1.47

3SBio, Semi-Annual Data
	Jun06	Dec06	Jun07	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of 3SBio,'s Price-to-Tangible-Book

For the Biotechnology subindustry, 3SBio,'s Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio,'s Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 3SBio,'s Price-to-Tangible-Book falls into.

3SBio, Price-to-Tangible-Book Calculation

3SBio,'s price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2016 )
	=	12.55	/	0.65
	=	19.31

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

3SBio, Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio, (FRA:YFK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.3sbio.com

3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines